/Lists

Biotech Investors & VC Firms in United States

1619 firms in this list, with a median first check of $500K. 402 of them lead rounds. Generated from verified public data and updated continuously.

Hunt BioVentures
DallasSeed–Growth
Texas Research & Technology Foundation / McDermott Pre-Seed Fund
San AntonioPre-Seed
Antler
SingaporePre-Seed–Series C$125K
327 people
Creative Destruction Lab (CDL)
TorontoPre-Seed–Seed$50K – $250K
155 people
Qiming Venture Partners
BeijingSeed–Series B
64 people
JAFCO Group
TokyoPre-Seed–Growth
91 people
Keensight Capital
ParisGrowth$10M – $800M
142 people
SV Health Investors
LondonSeed–Late Stage$1M – $20M
88 people
Aju IB Investment
SeoulGrowth
39 people
Wavemaker Partners
SingaporeSeed–Series A$100K – $2.5M
56 people
Blackbird Ventures
SydneyPre-Seed–Series B$149K – $60M
51 people
Nippon Venture Capital
TokyoPre-Seed–Growth$300K – $5M
62 people
Korea Investment Partners
SeoulSeed–Series C$3M – $10M
80 people
Gimv
AntwerpGrowth–Late Stage$21M – $430M
101 people
Omnes Capital
ParisSeries A–Growth
73 people
SBI Investment Korea Co. Ltd.
SeoulSeries A–Series C$200K – $10M
33 people
Dementia Discovery Fund
LondonSeed–Late Stage
81 people
Sky9 Capital
SingaporePre-Seed–Growth$1M – $10M
48 people
Rabo Corporate Venturing
UtrechtSeed–Series B$1M – $5M
57 people
Birch Hill Equity Partners Management Inc.
TorontoGrowth–Late Stage$75M – $3B
74 people
Elaia
ParisSeed–Series C$108K – $1.6M
45 people
Novo Holdings
HellerupSeed–Late Stage$1.1M – $54M
48 people
Antler Australia
SingaporePre-Seed–Growth$260K
63 people
DG Daiwa Ventures
TokyoPre-Seed–Growth
32 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.